357 related articles for article (PubMed ID: 20166088)
1. Tirilazad for aneurysmal subarachnoid haemorrhage.
Zhang S; Wang L; Liu M; Wu B
Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
3. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
Rinkel GJ; Feigin VL; Algra A; Vermeulen M; van Gijn J
Cochrane Database Syst Rev; 2002; (4):CD000277. PubMed ID: 12519539
[TBL] [Abstract][Full Text] [Related]
6. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM; Rinkel GJ; Feigin VL; Algra A; van den Bergh WM; Vermeulen M; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD000277. PubMed ID: 17636626
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.
Feigin VL; Anderson N; Rinkel GJ; Algra A; van Gijn J; Bennett DA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004583. PubMed ID: 16034939
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Germans MR; Dronkers WJ; Baharoglu MI; Post R; Verbaan D; Rinkel GJ; Roos YB
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001245. PubMed ID: 36350005
[TBL] [Abstract][Full Text] [Related]
9. Tirilazad for acute ischaemic stroke.
Bath PM; Iddenden R; Bath FJ; Orgogozo JM;
Cochrane Database Syst Rev; 2001; (4):CD002087. PubMed ID: 11687138
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Baharoglu MI; Germans MR; Rinkel GJ; Algra A; Vermeulen M; van Gijn J; Roos YB
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD001245. PubMed ID: 23990381
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
Rinkel GJ; Feigin VL; Algra A; van den Bergh WM; Vermeulen M; van Gijn J
Cochrane Database Syst Rev; 2005 Jan; (1):CD000277. PubMed ID: 15674871
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage.
Liu Z; Liu L; Zhang Z; Chen Z; Zhao B
Cochrane Database Syst Rev; 2013 Apr; (4):CD008184. PubMed ID: 23633351
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists for subarachnoid hemorrhage.
Guo J; Shi Z; Yang K; Tian JH; Jiang L
Cochrane Database Syst Rev; 2012 Sep; (9):CD008354. PubMed ID: 22972119
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD006184. PubMed ID: 17943892
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Roos YB; Rinkel GJ; Vermeulen M; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (2):CD001245. PubMed ID: 12804399
[TBL] [Abstract][Full Text] [Related]
17. Tirilazad mesylate in acute ischemic stroke: A systematic review. Tirilazad International Steering Committee.
Stroke; 2000 Sep; 31(9):2257-65. PubMed ID: 10978061
[TBL] [Abstract][Full Text] [Related]
18. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage.
Liu GJ; Luo J; Zhang LP; Wang ZJ; Xu LL; He GH; Zeng YJ; Wang YF
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):834-44. PubMed ID: 21999736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
